| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $8,266 | 1 | 100 |
| Swirsky Douglas J | CHIEF FINANCIAL OFFICER | 0 | $0 | 1 | $8,266 | $-8,266 |
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume …
Over the last 12 months, insiders at MaxCyte, Inc. have bought $0 and sold $8,266 worth of MaxCyte, Inc. stock.
On average, over the past 5 years, insiders at MaxCyte, Inc. have bought $439,880 and sold $12.28M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $64,500 was made by Brooke William W (director) on 2025‑08‑13.
| 2026-03-17 | Sale | Swirsky Douglas J | CHIEF FINANCIAL OFFICER | 10,142 0.0097% | $0.81 | $8,266 | +45.00% | |
| 2025-08-13 | Erck Stanley C | director | 100,000 0.0933% | $1.37 | $137,220 | -10.87% | ||
| 2025-08-13 | DOUGLAS RICHARD | director | 80,000 0.0755% | $1.39 | $111,040 | -10.87% | ||
| 2025-08-13 | Masoud Maher | President and CEO | 75,000 0.07% | $1.37 | $102,915 | -10.87% | ||
| 2025-08-13 | Swirsky Douglas J | CHIEF FINANCIAL OFFICER | 50,000 0.0438% | $1.29 | $64,500 | -10.87% | ||
| 2025-08-13 | Brooke William W | director | 50,000 0.0438% | $1.29 | $64,500 | -10.87% | ||
| 2025-06-25 | Sale | Hemrajani Rekha | director | 10,684 0.0094% | $2.09 | $22,378 | -37.67% | |
| 2025-03-18 | Sale | Swirsky Douglas J | CHIEF FINANCIAL OFFICER | 6,939 0.0066% | $3.18 | $22,061 | -49.53% | |
| 2025-03-18 | Sale | Sandoval David I. | GENERAL COUNSEL | 353 0.0003% | $3.18 | $1,122 | -49.53% | |
| 2025-03-18 | Sale | Soleymannezhad Ali | Chief Commercial Officer | 1,211 0.0011% | $3.18 | $3,850 | -49.53% | |
| 2025-01-27 | Sale | Johnston John Joseph | director | 3,000 0.0029% | $4.64 | $13,935 | -53.98% | |
| 2025-01-13 | Sale | Sandoval David I. | GENERAL COUNSEL | 4,466 0.0039% | $4.54 | $20,272 | -56.21% | |
| 2024-12-26 | Sale | Johnston John Joseph | director | 3,000 0.0028% | $4.01 | $12,021 | -45.95% | |
| 2024-12-09 | Sale | Johnston John Joseph | director | 2,495 0.0021% | $3.79 | $9,459 | -46.28% | |
| 2024-12-06 | Sale | Johnston John Joseph | director | 505 0.0005% | $3.70 | $1,869 | -37.50% | |
| 2024-11-01 | Sale | Erck Stanley C | director | 47,689 0.0448% | $3.72 | $177,403 | -35.54% | |
| 2024-10-28 | Sale | Johnston John Joseph | director | 3,000 0.0028% | $3.72 | $11,166 | -29.64% | |
| 2024-10-02 | Sale | Erck Stanley C | director | 21,607 0.0196% | $3.71 | $80,162 | -24.73% | |
| 2024-10-01 | Sale | Erck Stanley C | director | 26,082 0.0241% | $3.78 | $98,590 | -23.78% | |
| 2024-09-26 | Sale | Johnston John Joseph | director | 3,000 0.0028% | $3.82 | $11,460 | -26.48% |
| Swirsky Douglas J | CHIEF FINANCIAL OFFICER | 151669 0.147% | $221,436.74 | 1 | 2 | <0.0001% |
| Casdin Partners Master Fund, L.P. | 10 percent owner | 10000000 9.6893% | $14.6M | 1 | 2 | <0.0001% |
| Erck Stanley C | director | 398328 0.386% | $581,558.88 | 1 | 5 | <0.0001% |
| DOUGLAS RICHARD | director | 230577 0.2234% | $336,642.42 | 3 | 0 | <0.0001% |
| Masoud Maher | President and CEO | 175000 0.1696% | $255,500.00 | 3 | 3 | <0.0001% |
| Brooke William W | director | 150879 0.1462% | $220,283.34 | 1 | 0 | <0.0001% |
| Increased Positions | 51 | +37.78% | 11M | +15.98% |
| Decreased Positions | 54 | -40% | 12M | -17.87% |
| New Positions | 24 | New | 8M | New |
| Sold Out Positions | 18 | Sold Out | 3M | Sold Out |
| Total Postitions | 132 | -2.22% | 66M | -1.89% |
| Blackrock, Inc. | $15,475.00 | 9.33% | 9.98M | -218,330 | -2.14% | 2025-09-30 |
| Cadian Capital Management, Lp | $12,753.00 | 7.69% | 8.23M | -686,873 | -7.71% | 2025-09-30 |
| Mirabella Financial Services Llp | $12,710.00 | 7.66% | 8.2M | +2M | +24.24% | 2025-09-30 |
| Morgan Stanley | $10,379.00 | 6.26% | 6.7M | -329,584 | -4.69% | 2025-09-30 |
| Vanguard Group Inc | $8,662.00 | 5.22% | 5.59M | -13,587 | -0.24% | 2025-09-30 |
| Vitruvian Partners Llp | $7,817.00 | 4.71% | 5.04M | 0 | 0% | 2025-09-30 |
| Mudita Advisors Llp | $5,225.00 | 3.15% | 3.37M | 0 | 0% | 2025-09-30 |
| Axa Investment Managers S.A. | $4,299.00 | 2.59% | 2.77M | +3M | New | 2025-09-30 |
| Geode Capital Management, Llc | $3,967.00 | 2.39% | 2.56M | +79,144 | +3.19% | 2025-09-30 |
| State Street Corp | $3,514.00 | 2.12% | 2.27M | +83,947 | +3.85% | 2025-09-30 |